Clinical Trial Update: Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances [Phase 3]

View source ↗

Summary

This Phase 3 trial assessed the safety and efficacy of Nyxol (0.75% phentolamine ophthalmic solution) for dim light vision disturbances. The study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dim Light Vision Disturbances

Drugs mentioned

• Nyxol (phentolamine ophthalmic solution 0.75%)

Snippet

Sponsor: Ocuphire Pharma, Inc. | Conditions: Dim Light Vision Disturbances | Phase 3 | Status: COMPLETED | Results posted: 2023-08-09